Compass Pathways has filed paperwork for a Nasdaq IPO that will tee it up to take psilocybin therapy COMP360 through midphase development. Compass is developing psilocybin, the active ingredient in ...

Compass Pathways Plc, the U.K. company that has patented a synthetic version of the active ingredient in so-called magic mushrooms for use in treatment-resistant depression, went public on Friday.

SINGAPORE / ACCESSWIRE / May 21, 2024 / On May 19th to May 20th local time, Magic Compass Group (hereinafter referred to as Magic Compass) was invited to showcase at the 2024 Dubai Forex Traders ...

An under-the-radar company has made enough of the active ingredient in magic mushrooms to send 20,000 people on a trip. Compass Pathways, which is based in London and boasts an advisory board of ...

Port-Louis, Mauritius, Oct. 15, 2024 (GLOBE NEWSWIRE) -- From September 16 to 18, Magic Compass Prime participated in iFX Asia 2024 in Bangkok. As a prominent event in Asia for financial companies, ...

A synthetic form of the active ingredient in magic mushrooms has cleared an early-phase trial. The drug, Compass Pathways’ COMP360, came through the placebo-controlled phase 1 without setting off any ...

George Goldsmith is the Chairman, CEO and Co‑Founder of COMPASS Pathways (NASDAQ:CMPS). Mr. Goldsmith’s early training and experience was a multi-disciplinary blending of cognitive psychology, ...

Magic Compass Prime is a subsidiary of Magic Compass Group, founded in 2006, with offices in Hong Kong, Singapore, and other locations. Magic Compass Group is committed to delivering innovative ...

Density. Shifting ground. Textural discord. Sharpness like glass. Resonant emptiness. Explorative improvisation, electronica sound spaces and electric beats. Released by the Craig Taborn project Junk ...